Literature DB >> 1569080

Sequence requirements for precursor cleavage within the constitutive secretory pathway.

T Watanabe1, T Nakagawa, J Ikemizu, M Nagahama, K Murakami, K Nakayama.   

Abstract

We have recently demonstrated that the Arg-X-Lys/Arg-Arg sequence is a signal for precursor cleavage catalyzed by furin, a mammalian homologue of the yeast precursor-processing endoprotease Kex2, within the constitutive secretory pathway. In this study, we further examined sequence requirements for the constitutive precursor cleavage by expression of various prorenin mutants with amino acid substitutions around the native Lys-Arg cleavage site in Chinese hamster ovary cells. The results delineate the following sequence rules that govern the constitutive precursor cleavage. (a) A basic residue (Lys or Arg) at the 4th (position -4) or 6th (position -6) residue upstream of the cleavage site besides basic residues at positions -1 and -2 is necessary. (b) At position -2, a Lys residue is more preferable than Arg. (c) At position -4, an Arg residue is more preferable than Lys. (d) At position 1, a hydrophobic aliphatic amino acid is not suitable.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1569080

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  27 in total

1.  Bridging neuropeptidomics and genomics with bioinformatics: Prediction of mammalian neuropeptide prohormone processing.

Authors:  Andinet Amare; Amanda B Hummon; Bruce R Southey; Tyler A Zimmerman; Sandra L Rodriguez-Zas; Jonathan V Sweedler
Journal:  J Proteome Res       Date:  2006-05       Impact factor: 4.466

2.  The chemorepulsive activity of secreted semaphorins is regulated by furin-dependent proteolytic processing.

Authors:  R H Adams; M Lohrum; A Klostermann; H Betz; A W Püschel
Journal:  EMBO J       Date:  1997-10-15       Impact factor: 11.598

Review 3.  Furin: a mammalian subtilisin/Kex2p-like endoprotease involved in processing of a wide variety of precursor proteins.

Authors:  K Nakayama
Journal:  Biochem J       Date:  1997-11-01       Impact factor: 3.857

4.  Stability of mutant serpin/furin complexes: dependence on pH and regulation at the deacylation step.

Authors:  Erick K Dufour; Antoine Désilets; Jean-Michel Longpré; Richard Leduc
Journal:  Protein Sci       Date:  2005-02       Impact factor: 6.725

5.  Proteolytic processing of the alpha-subunit of rat endopeptidase-24.18 by furin.

Authors:  P E Milhiet; S Chevallier; D Corbeil; N G Seidah; P Crine; G Boileau
Journal:  Biochem J       Date:  1995-07-15       Impact factor: 3.857

6.  Comparative biosynthesis, covalent post-translational modifications and efficiency of prosegment cleavage of the prohormone convertases PC1 and PC2: glycosylation, sulphation and identification of the intracellular site of prosegment cleavage of PC1 and PC2.

Authors:  S Benjannet; N Rondeau; L Paquet; A Boudreault; C Lazure; M Chrétien; N G Seidah
Journal:  Biochem J       Date:  1993-09-15       Impact factor: 3.857

7.  A Kex2-related endopeptidase activity present in rat liver specifically processes the insulin proreceptor.

Authors:  C Alarcón; B Cheatham; B Lincoln; C R Kahn; K Siddle; C J Rhodes
Journal:  Biochem J       Date:  1994-07-01       Impact factor: 3.857

8.  Substrate specificity of proinsulin conversion in the constitutive pathway of transfected FAO (hepatoma) cells.

Authors:  F Vollenweider; J C Irminger; P A Halban
Journal:  Diabetologia       Date:  1993-12       Impact factor: 10.122

9.  Proinsulin processing by the subtilisin-related proprotein convertases furin, PC2, and PC3.

Authors:  S P Smeekens; A G Montag; G Thomas; C Albiges-Rizo; R Carroll; M Benig; L A Phillips; S Martin; S Ohagi; P Gardner
Journal:  Proc Natl Acad Sci U S A       Date:  1992-09-15       Impact factor: 11.205

10.  Mammalian subtilisin-related proteinases in cleavage activation of the paramyxovirus fusion glycoprotein: superiority of furin/PACE to PC2 or PC1/PC3.

Authors:  B Gotoh; Y Ohnishi; N M Inocencio; E Esaki; K Nakayama; P J Barr; G Thomas; Y Nagai
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.